Pursuant to Regulation 30 0f Listing Regulations, please find enclosed Press Release- \Wockhardt's Fifth Novel Antibiotic, Foviscu (WCK 4282), Matches Gold Standard Meropenem in pivotal Phase 3 Trial as First-Line Therapies Fail Against Rising Resistance.\: